Literature DB >> 8929657

Symptoms and personality characteristics of patients in a maximum security psychiatric unit.

K Rasmussen1, S Levander.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8929657     DOI: 10.1016/0160-2527(95)00018-6

Source DB:  PubMed          Journal:  Int J Law Psychiatry        ISSN: 0160-2527


× No keyword cloud information.
  6 in total

1.  Chronic tiagabine administration and aggressive responding in individuals with a history of substance abuse and antisocial behavior.

Authors:  Joshua L Gowin; Charles E Green; Joseph L Alcorn; Alan C Swann; F Gerard Moeller; Scott D Lane
Journal:  J Psychopharmacol       Date:  2011-07-05       Impact factor: 4.153

2.  Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior.

Authors:  Scott D Lane; Joshua L Gowin; Charles E Green; Joel L Steinberg; F Gerard Moeller; Don R Cherek
Journal:  Pharmacol Biochem Behav       Date:  2009-04       Impact factor: 3.533

3.  Effects of Intranasal Oxytocin on Aggressive Responding in Antisocial Personality Disorder.

Authors:  Joseph L Alcorn; Nuvan Rathnayaka; Alan C Swann; F Gerard Moeller; Scott D Lane
Journal:  Psychol Rec       Date:  2015-09-09

4.  Schizotypy and psychopathic tendencies interactively improve misattribution of affect in boys with conduct problems.

Authors:  Steven M Gillespie; Mickey T Kongerslev; Sune Bo; Ahmad M Abu-Akel
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-05-31       Impact factor: 4.785

5.  Relationships between dimensional factors of psychopathy and schizotypy.

Authors:  Katie A Ragsdale; Jeffrey S Bedwell
Journal:  Front Psychol       Date:  2013-07-26

6.  Factors and predictors of length of stay in offenders diagnosed with schizophrenia - a machine-learning-based approach.

Authors:  Johannes Kirchebner; Moritz Philipp Günther; Martina Sonnweber; Alice King; Steffen Lau
Journal:  BMC Psychiatry       Date:  2020-05-06       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.